{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:06:04Z","timestamp":1787162764147,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clnu.2025.02.031","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T11:20:35Z","timestamp":1740828035000},"page":"242-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Association between body composition parameters and treatment-related toxicities in patients with metastatic breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors"],"prefix":"10.1016","volume":"47","author":[{"given":"Giovanni","family":"Imbimbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Scagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pisegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gallicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Botticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-0236","authenticated-orcid":false,"given":"Alessio","family":"Molfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2025.02.031_bib1","unstructured":"WHO. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer [n.d]."},{"key":"10.1016\/j.clnu.2025.02.031_bib2","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clnu.2025.02.031_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1903765","article-title":"Overall survival with Ribociclib plus endocrine therapy in breast cancer","volume":"381","author":"Im","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2025.02.031_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.critrevonc.2018.06.011","article-title":"Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer","volume":"129","author":"Trestini","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clnu.2025.02.031_bib5","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","article-title":"Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies","volume":"25","author":"Chan","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clnu.2025.02.031_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clnu.2025.02.031_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SPC.0b013e32833e4aa5","article-title":"Contribution of anorexia to tissue wasting in cachexia","volume":"4","author":"Molfino","year":"2010","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clnu.2025.02.031_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00280-024-04641-z","article-title":"Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4\/6 inhibitors","volume":"93","author":"Y\u00fccel","year":"2024","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clnu.2025.02.031_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/00140139.2010.489653","article-title":"Systems modelling approaches to the design of safe healthcare delivery: ease of use and usefulness perceived by healthcare workers","volume":"53","author":"Jun","year":"2010","journal-title":"Ergonomics"},{"key":"10.1016\/j.clnu.2025.02.031_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jcsm.12893","article-title":"Histomorphological and inflammatory changes of white adipose tissue in gastrointestinal cancer patients with and without cachexia","volume":"13","author":"Molfino","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2025.02.031_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1449197","article-title":"Circulating adipose-tissue miRNAs in gastrointestinal cancer patients and their association with the level and type of adiposity at body composition analysis","volume":"11","author":"Tambaro","year":"2024","journal-title":"Front Mol Biosci"},{"issue":"23","key":"10.1016\/j.clnu.2025.02.031_bib12","first-page":"S0953","article-title":"Muscularity and adiposity are differently associated with inflammatory and nutritional biomarkers among patients on hemodialysis and peritoneal dialysis","author":"Molfino","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clnu.2025.02.031_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000527917","article-title":"CDK4\/6 inhibitors in advanced HR+\/HER2 - breast cancer: a multicenter real-world data analysis","volume":"18","author":"M\u00fcller","year":"2023","journal-title":"Breast Care"},{"key":"10.1016\/j.clnu.2025.02.031_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.20312","article-title":"Association of cyclin-dependent kinases 4 and 6 inhibitors with survival in patients with hormone receptor\u2013positive metastatic breast cancer: a systematic review and meta-analysis","volume":"3","author":"Li","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clnu.2025.02.031_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.21037\/apm.2018.08.02","article-title":"Sarcopenia associated with chemotherapy and targeted agents for cancer therapy","volume":"8","author":"Davis","year":"2019","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.clnu.2025.02.031_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-020-05617-2","article-title":"Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4\/6 inhibitors","volume":"181","author":"Franzoi","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clnu.2025.02.031_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112526","article-title":"Identifying low muscle mass and monitoring body composition changes in newly diagnosed cancer patients: agreement between multifrequency bioelectrical impedance analysis and computed tomography","volume":"128","author":"Wang","year":"2024","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2025.02.031_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clnu.2025.02.031_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T16:46:15Z","timestamp":1745513175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561425000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":19,"alternative-id":["S0261561425000664"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2025.02.031","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between body composition parameters and treatment-related toxicities in patients with metastatic breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2025.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}